Related Experiment Video
Updated: Mar 30, 2026
10:33
Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
Published on: December 17, 2021
3.3K
Mycophenolate Mofetil Therapy in Refractory Inflammatory Eye Disease
Miguel Cuchacovich1, Federica Solanes2, Claudio Perez3
11 Department of Medicine, Clinical Hospital University of Chile , Santiago, Chile .
Summary
Mycophenolate mofetil (MMF) effectively controls noninfectious inflammatory eye diseases and reduces corticosteroid use. The treatment showed an acceptable safety profile in this patient cohort.
Area of Science:
- Ophthalmology
- Immunosuppressive therapy
- Inflammatory diseases
Background:
- Noninfectious inflammatory eye diseases require long-term management.
- Corticosteroids are a common treatment but have significant side effects.
- Alternative immunosuppressive agents are needed to spare corticosteroid use.
Purpose of the Study:
- To evaluate the efficacy of mycophenolate mofetil (MMF) in treating noninfectious inflammatory eye diseases.
- To determine the incidence of treatment-related side effects associated with MMF therapy.
- To assess MMF's potential as a corticosteroid-sparing agent.
Main Methods:
- Retrospective cohort study involving 27 Chilean patients.
- Patients were treated for noninfectious inflammatory eye diseases with MMF over 10 years.
- Outcomes included control of ocular inflammation, prednisone tapering, and side effect incidence.
Main Results:
- Sustained control of ocular inflammation was achieved in 81.48% of patients at 6 months.
- Prednisone tapering to ≤10 mg/day was successful in 55.56% of patients at 6 months.
- Two patients developed neoplasia, but the small cohort size limits interpretation of this finding.
Conclusions:
- Mycophenolate mofetil (MMF) demonstrates efficacy in managing noninfectious inflammatory eye diseases.
- MMF serves as an effective corticosteroid-sparing agent.
- The safety profile of MMF in this context appears acceptable.
Related Concept Videos
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
669
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
669
01:29Inflammatory Bowel Disease IV: Pharmacological Management
935
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
935
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
629
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
629
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
741
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
741
01:28Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K